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Letter to the Editor
Intestine transplantation: case report
Transplante de intestino: relato de caso
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Intestine transplantation (ITx) is one of the 
greatest challenges in modern medicine. It is a very 
sophisticated procedure that can be performed isolated 
or combined with other organs of the gastrointestinal 
tract, such as stomach, duodenum, liver and pâncreas in 
a multivisceral transplantation. Primary indications for 
ITx mainly involves patients with Short Bowel Syndrome 
(SBC) complications, such as depletion of central venous 
access caused by thrombosis or multiple episodes of 
catheter related infections due to parenteral nutrition, 
alterations of growth and development in children, liver 
disease and refractory electrolyte changes1-4,7. In adults, 
SBC is generally caused by Crohn disease, mesenteric 
thrombosis, trauma, desmoid tumors and complications 
from gastrointestinal surgeries. In Children, the main 
causes are congenital anomalies, mid gut volvulus, 
gastroschisis, intestinal atresia, necrotizing enterocolitis 
and motility disorders5-6. 
In Brazil and around the World, the development 
of ITx has been slow and the number of patients who 
undergo this procedure is much lower than other 
solid organ transplantations. One of the main causes 
for this difference is the lack of knowledge about 
immunosuppressive therapy, which generally leads to 
graft rejection. Studies have shown that 50%-75% of ITx 
patients experience acute rejection, while 15% experience 
chronic rejection4. The lack of centers specialized in 
ITx is another issue. In Brazil, there is just two centers 
(HCFMUSP and HIAE) currently performing intestinal 
transplantation and the casuistic is incipiente (just 10 
cases), which makes the experience in this procedure and 
in the immunosuppressive therapy quite limited.
Considering the importance of studying a great 
number of ITx cases to develop this procedure in Brazil, 
we report a case of intestine transplantation that has 
evolved with emergency removal of the graft due to 
acute rejection and failure of the clinical treatment in 
HCFMUSP. 
The patient is a 21 years old male who developed 
Short Bowel Syndrome after complications from a 
appendectomy in 2015. He was indicated and undergone 
ITx in 2016 due to several catheter related infections. Six 
months after the procedure, the patient started to have 
complications from immunosuppressive theraphy, when 
he was successfully treated for systemic histoplasmosis. 
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At the 18th postoperative month, he was admitted 
with fever and intense diarrhea. Image and laboratory 
exames were consistent with severe acute rejection and 
the patient was unsuccessfully treated with high doses 
of immunosuppressive medications. A few days later, 
his clinical condition worsened, which leaded to the 
urgent removal of the transplanted graft. The patient`s 
general condition improved and parenteral nutrition was 
reintroduced. 
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